Residual β cell function and monogenic variants in long-duration type 1 diabetes patients.

BACKGROUNDIn the Joslin Medalist Study (Medalists), we determined whether significant associations exist between β cell function and pathology and clinical characteristics.METHODSIndividuals with type 1 diabetes (T1D) for 50 or more years underwent evaluation including HLA analysis, basal and longitudinal autoantibody (AAb) status, and β cell function by a mixed-meal tolerance test (MMTT) and a hyperglycemia/arginine clamp procedure. Postmortem analysis of pancreases from 68 Medalists was performed. Monogenic diabetes genes were screened for the entire cohort.RESULTSOf the 1019 Medalists, 32.4% retained detectable C-peptide levels (>0.05 ng/mL, median: 0.21 ng/mL). In those who underwent a MMTT (n = 516), 5.8% responded with a doubling of baseline C-peptide levels. Longitudinally (n = 181, median: 4 years), C-peptide levels increased in 12.2% (n = 22) and decreased in 37% (n = 67) of the Medalists. Among those with repeated MMTTs, 5.4% (3 of 56) and 16.1% (9 of 56) had waxing and waning responses, respectively. Thirty Medalists with baseline C-peptide levels of 0.1 ng/mL or higher underwent the clamp procedure, with HLA-/AAb- and HLA+/AAb- Medalists being most responsive. Postmortem examination of pancreases from 68 Medalists showed that all had scattered insulin-positive cells; 59 additionally had few insulin-positive cells within a few islets; and 14 additionally had lobes with multiple islets with numerous insulin-positive cells. Genetic analysis revealed that 280 Medalists (27.5%) had monogenic diabetes variants; in 80 (7.9%) of these Medalists, the variants were classified as "likely pathogenic" (rare exome variant ensemble learner [REVEL] >0.75).CONCLUSIONAll Medalists retained insulin-positive β cells, with many responding to metabolic stimuli even after 50 years of T1D. The Medalists were heterogeneous with respect to β cell function, and many with HLA+ diabetes risk alleles also had monogenic diabetes variants, indicating the importance of genetic testing for clinically diagnosed T1D.FUNDINGFunding for this work was provided by the Dianne Nunnally Hoppes Fund; the Beatson Pledge Fund; the NIH, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); and the American Diabetes Association (ADA).

[1]  R. Oram,et al.  Beta cells in type 1 diabetes: mass and function; sleeping or dead? , 2019, Diabetologia.

[2]  J. Kushner,et al.  Low-Level Insulin Content Within Abundant Non-β Islet Endocrine Cells in Long-standing Type 1 Diabetes , 2018, Diabetes.

[3]  Teresa L. Mastracci,et al.  Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes , 2018, Diabetes Care.

[4]  André Rodrigues,et al.  Mellitus , 2018, Proceedings of the 17th International Conference on Mobile and Ubiquitous Multimedia.

[5]  S. Begum,et al.  Sequence Alignment , 2018, Beginners Guide to Bioinformatics for High Throughput Sequencing.

[6]  Quan Li,et al.  InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. , 2017, American journal of human genetics.

[7]  Trevor Hastie,et al.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. , 2016, American journal of human genetics.

[8]  P. Bingley,et al.  Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes , 2016, Diabetologia.

[9]  P. Butler,et al.  Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.

[10]  J. González-Rodríguez,et al.  Identification of unsuspected Wolfram syndrome cases through clinical assessment and WFS1 gene screening in type 1 diabetes mellitus patients. , 2015, Gene.

[11]  S. Pascarella,et al.  Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus. , 2015, American journal of human genetics.

[12]  Jennifer K. Sun,et al.  Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences , 2015, Diabetes Care.

[13]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[14]  B. Shields,et al.  Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors , 2014, Diabetes Care.

[15]  Carla J. Greenbaum,et al.  Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes , 2014, Diabetes Care.

[16]  J. Lachin,et al.  Insulin secretion measured by stimulated C‐peptide in long‐established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[17]  M. Rickels,et al.  Assessment of β-Cell Mass and α- and β-Cell Survival and Function by Arginine Stimulation in Human Autologous Islet Recipients , 2014, Diabetes.

[18]  D. Reich,et al.  Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture , 2012, Genome research.

[19]  D. Faustman,et al.  Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay , 2012, Diabetes Care.

[20]  Jennifer K. Sun,et al.  Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration , 2011, Diabetes Care.

[21]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[22]  Jennifer K. Sun,et al.  Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study , 2010, Diabetes.

[23]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[24]  C. Cobelli,et al.  Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy , 2010, Diabetologia.

[25]  P. Herrera,et al.  Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss , 2010, Nature.

[26]  S. Bonner-Weir,et al.  Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction , 2009, Proceedings of the National Academy of Sciences.

[27]  E. Mayer-Davis,et al.  Preservation of β-Cell Function in Autoantibody-Positive Youth With Diabetes , 2009, Diabetes Care.

[28]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[29]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[30]  J. Rehfeld,et al.  Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes , 2009, Diabetes Care.

[31]  T. Hansen,et al.  Mutations in the VNTR of the carboxyl-ester lipase gene (CEL) are a rare cause of monogenic diabetes , 2009, Human Genetics.

[32]  P. in’t Veld,et al.  The beta cell population in type 1 diabetes. , 2008, Novartis Foundation symposium.

[33]  Geir Joner,et al.  Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes , 2008, Diabetes.

[34]  R. Rizza,et al.  Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis , 2007, Diabetologia.

[35]  Robert A Hegele,et al.  0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(7):2689–2695 Printed in U.S.A. Copyright © 2006 by The Endocrine Society doi: 10.1210/jc.2005-2746 A LMNA Splicing Mutation in Two Sisters with Severe Dunnigan-Type Familial Parti , 2022 .

[36]  R. Rizza,et al.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? , 2005, Diabetologia.

[37]  M. Löhr,et al.  Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy , 1987, Diabetologia.

[38]  S. Norgren,et al.  The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome , 2001, Human Genetics.

[39]  G. Lathrop,et al.  EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome , 2000, Nature Genetics.

[40]  Timothy Barrett,et al.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness , 1999, Nature Genetics.

[41]  Å. Lernmark,et al.  Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. , 1999, Diabetes.

[42]  古田 浩人.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1999 .

[43]  R. Sorenson,et al.  Adaptation of Islets of Langerhans to Pregnancy: β-Cell Growth, Enhanced Insulin Secretion and the Role of Lactogenic Hormones , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[44]  William L. Clarke,et al.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.

[45]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[46]  M. Rewers,et al.  Antiislet autoantibodies usually develop sequentially rather than simultaneously. , 1996, The Journal of clinical endocrinology and metabolism.

[47]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.

[48]  G. Grodsky,et al.  A New Phase Of Insulin Secretion: How Will It Contribute to Our Understanding of β-Cell Function? , 1989, Diabetes.

[49]  W. Gepts.  Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.